Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing ...

Aduna , the global aggregator of network APIs, and NTT DOCOMO, Inc., one of Japan's leading mobile operators with over 91 million subscribers, today announced an intention to ...

Miscellaneous PIERER Mobility AG: Restructuring plans for KTM AG, KTM Components GmbH, and KTM Forschungs & Entwicklungs GmbH are legally binding 17.06.2025 / 07:33 CET/CEST The issuer is solely ...

MedHub-AI , pioneer of AI-based FFR "AutocathFFR" software, today announced a distribution agreement with Terumo Corporation to bring AutocathFFR ® , its groundbreaking ...

Aduna , the global aggregator of network APIs, today announced that it has entered into a strategic commercial partnership with SoftBank Corp. ("SoftBank") as part of a ...

Stan Miller appointed CEO to lead United Group as it strategically refocuses its business on EU markets following successful sale of non-EU operations Together with Stan, Libor Voncina appointed ...

Innovative Molecules GmbH today announced the completion of enrollment in the Phase 1b portion of its ongoing Phase 1b/2a clinical trial evaluating IM-250, a next-generation helicase-primase inhibitor ...

Quarter Results Q1 2025: Wolftank Group increases sales by 10% to EUR 25.7 million 12.06.2025 / 09:30 CET/CEST The issuer is solely responsible for the content of this announcement.

This new feature will turn the operational database into a powerful native AI engine, responding to the growing demand for engineering teams to deliver ...

EQS-News: Schoeller-Bleckmann Oilfield Equipment AG / Key word(s): Expansion SBO inaugurates expanded facility in Vietnam and strengthens global supply chain flexibility 12.06.2025 / 10:00 CET/CEST ...

Annual Results voestalpine AG: voestalpine generates solid result in the 2024/25 business year despite difficult environment 04.06.2025 / 07:30 CET/CEST The issuer is solely responsible for the ...

Vienna-based researchers are now trying to combine molecular biological markers with other diagnostic procedures, which could provide clues to possible therapies.